Antibiotics Linked to Retinal Detachment RiskLast Updated: April 03, 2012. The risk is very small and the reasons aren't known, researchers say.
By Steven Reinberg
TUESDAY, April 3 (HealthDay News) -- People taking antibiotics called fluoroquinolones may be at a small risk of an eye condition called retinal detachment, a new study suggests.
These commonly prescribed antibiotics, used to fight a variety of bacterial infections, have been linked to other eye problems, including corneal perforations, optic neuropathy and retinal hemorrhages. But this is the first study that has linked them to retinal detachment, a serious medical emergency that may lead to blindness, the Canadian researchers said.
"These are powerful antibiotics, so they should only be used in patients who really need them, as many studies show they are inappropriately prescribed," said lead researcher Dr. Mahyar Etminan, an assistant professor of medicine at the Child and Family Research Institute of British Columbia in Vancouver.
"Patients who experience floaters or flashes of light in their visual field while taking these drugs should see an ophthalmologist to prevent possible retinal detachment," he added.
"Since this condition is serious and may lead to severe loss of visual acuity or even blindness, patients taking these drugs should be familiar with these signs," he said.
The report was published in the April 4 issue of the Journal of the American Medical Association.
For the study, Etminan's team analyzed records of almost 1 million patients who saw an ophthalmologist between January 2000 and December 2007.
Among these patients, more than 4,300 had a retinal detachment. The researchers paired each of these patients with 10 individuals who did not have the condition.
The investigators found that those suffering a retinal detachment were more likely to be near-sighted, have diabetes or have had cataract surgery.
In addition, 3.3 percent of those with a retinal detachment were taking fluoroquinolones, compared with 0.6 percent of those without the condition, the study authors noted.
However, there was no risk of retinal detachment among people who had taken the antibiotics recently or those who had taken them in the past, the study found.
And while current users of fluoroquinolones had a nearly five times higher risk of retinal detachment, the absolute risk was very small -- only 1 in 2,500, for any use of fluoroquinolones, they noted.
"This magnitude of risk seems small, but given that there are about 40,000,000 prescriptions written for these drugs in the U.S., it translates to around 4,000 new cases per year," Etminan said.
The study does not establish a cause-and-effect relationship between antibiotics and retinal detachment, only a weak association.
Commenting on the study, Dr. William Smiddy, a professor of ophthalmology at the University of Miami Bascom Palmer Eye Institute, said, "I don't believe it."
If the risk were real, you would expect to find people who had taken the antibiotics to have had the condition, but the study didn't find that, he said.
"It's not something we can discount, but it's hard to believe," Smiddy added. "It's not something I've even heard described, before this paper."
In addition, Smiddy noted that the study only suggests there may be a connection.
"Even if there is a risk, it's a low risk, so if you need a fluoroquinolone you should be on a fluoroquinolone," Smiddy said. "We don't want to throw the baby out with the bathwater."
For more information on detached retina, visit the U.S. National Library of Medicine.
SOURCES: Mahyar Etminan, Pharm.D., M.Sc., assistant professor of medicine, Child and Family Research Institute, British Columbia, Vancouver, Canada; William Smiddy, M.D., professor of ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine; April 4, 2012, Journal of the American Medical Association
|Previous: Ultrasound, MRI Might Spot Cancer in Dense Breast Tissue||Next: Reported Decline in U.S. Pneumonia Deaths May Be False: Study|
Reader comments on this article are listed below. Review our comments policy.